ITIH3 is a Potential Biomarker for Early Detection of Gastric Cancer

Overview

Journal J Proteome Res

Publisher American Chemical Society

Specialty Biochemistry

Date 2010 Jun 3

PMID 20515073

Citations 36

Authors

Poh Kuan Chong

Huiyin Lee

Jianbiao Zhou

Shaw-Cheng Liu

Marie Chiew Shia Loh

Ting Ting Wang

Siew Pang Chan

Duane T Smoot

Hassan Ashktorab

Jimmy Bok Yan So

Khong Hee Lim

Khay Guan Yeoh

Yoon Pin Lim

Affiliations

Soon will be listed here.

Abstract

Gastric cancer has one of the highest morbidities and mortalities worldwide. Early detection is key measure to improve the outcome of gastric cancer patients. In our efforts to identify potential markers for gastric cancer detection, we coupled xenotransplantation mouse model with a plasma proteomic approach. MKN45 gastric cancer cells were subcutaneously injected into nude mice and plasma samples from mice bearing different sizes of tumors were collected and subjected to iTRAQ and mass spectrometry analysis. ITIH3 protein was found to be more highly expressed in plasma of tumor bearing mice compared to control. Subsequent screening of ITIH3 expression in 167 clinical plasma samples, including 83 cancer-free subjects and 84 gastric cancer patients, revealed higher ITIH3 level in the plasma of gastric cancer patients. A receiver operating characteristics (ROC) curve estimated a maximal sensitivity of 96% at 66% specificity for ITIH3 in gastric cancer detection. In addition, plasma from early stage gastric cancer patient has significantly (p < 0.001) higher level of ITIH3 compared to that from noncancer subject. Our data suggest that ITIH3 may be a useful biomarker for early detection of gastric cancer.

Citing Articles

The function of the inter-alpha-trypsin inhibitors in the development of disease.

Zhang X, Zhang X, Guo L, Bai Y, Tian Y, Luo H Front Med (Lausanne). 2024; 11:1432224.

PMID: 39149600 PMC: 11325723. DOI: 10.3389/fmed.2024.1432224.

Identification of Serum Biomarkers to Monitor Therapeutic Response in Intestinal-Type Gastric Cancer.

Dagley L, Yousef J, Preaudet A, Loving A, Webb A, Ernst M Int J Mol Sci. 2024; 25(6).

PMID: 38542101 PMC: 10970471. DOI: 10.3390/ijms25063129.

A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes.

Li B, Kugeratski F, Kalluri R Elife. 2024; 12.

PMID: 38529947 PMC: 10965221. DOI: 10.7554/eLife.90390.

Identification of a novel gene signature related to prognosis and metastasis in gastric cancer.

Elizazu J, Artetxe-Zurutuza A, Otaegi-Ugartemendia M, Moncho-Amor V, Moreno-Valladares M, Matheu A Cell Oncol (Dordr). 2024; 47(4):1355-1373.

PMID: 38480611 PMC: 11322236. DOI: 10.1007/s13402-024-00932-y.

Exploration of potential biomarkers for early bladder cancer based on urine proteomics.

Zhou X, Xue F, Li T, Xue J, Yue S, Zhao S Front Oncol. 2024; 14:1309842.

PMID: 38410113 PMC: 10894981. DOI: 10.3389/fonc.2024.1309842.

References

Shilov I, Seymour S, Patel A, Loboda A, Tang W, Keating S . The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007; 6(9):1638-55. DOI: 10.1074/mcp.T600050-MCP200. View

Cerwenka H, Aigner R, Bacher H, Werkgartner G, El-Shabrawi A, Quehenberger F . TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions. Anticancer Res. 1999; 19(1B):849-51. View

Chatterji B, Borlak J . A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice. Proteomics. 2009; 9(4):1044-56. DOI: 10.1002/pmic.200701135. View

Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N . The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation. Oncogene. 2007; 27(6):865-76. DOI: 10.1038/sj.onc.1210669. View

Miki K, Fujishiro M, Kodashima S, Yahagi N . Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population. Dig Endosc. 2009; 21(2):78-81. DOI: 10.1111/j.1443-1661.2009.00839.x. View

Lim Y, Low B, Lim J, Wong E, Guy G . Association of atypical protein kinase C isotypes with the docker protein FRS2 in fibroblast growth factor signaling. J Biol Chem. 1999; 274(27):19025-34. DOI: 10.1074/jbc.274.27.19025. View

Pitteri S, Faca V, Kelly-Spratt K, Kasarda A, Wang H, Zhang Q . Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. J Proteome Res. 2008; 7(4):1481-9. DOI: 10.1021/pr7007994. View

van Weerden W, Romijn J . Use of nude mouse xenograft models in prostate cancer research. Prostate. 2000; 43(4):263-71. DOI: 10.1002/1097-0045(20000601)43:4<263::aid-pros5>3.0.co;2-i. View

Gan C, Chong P, Pham T, Wright P . Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J Proteome Res. 2007; 6(2):821-7. DOI: 10.1021/pr060474i. View

10.

Hardt P, Ngoumou B, Rupp J, Kloer H . Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer. Anticancer Res. 2001; 20(6D):4965-8. View

11.

Pierce A, Unwin R, Evans C, Griffiths S, Carney L, Zhang L . Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases. Mol Cell Proteomics. 2007; 7(5):853-63. DOI: 10.1074/mcp.M700251-MCP200. View

12.

Ebert M, Rocken C . Molecular screening of gastric cancer by proteome analysis. Eur J Gastroenterol Hepatol. 2006; 18(8):847-53. DOI: 10.1097/00042737-200608000-00007. View

13.

Kobayashi H, Shinohara H, Fujie M, Gotoh J, Itoh M, Takeuchi K . Inhibition of metastasis of Lewis lung carcinoma by urinary trypsin inhibitor in experimental and spontaneous metastasis models. Int J Cancer. 1995; 63(3):455-62. DOI: 10.1002/ijc.2910630326. View

14.

Hamm A, Veeck J, Bektas N, Wild P, Hartmann A, Heindrichs U . Frequent expression loss of Inter-alpha-trypsin inhibitor heavy chain (ITIH) genes in multiple human solid tumors: a systematic expression analysis. BMC Cancer. 2008; 8:25. PMC: 2268946. DOI: 10.1186/1471-2407-8-25. View

15.

Paris S, Sesboue R, Delpech B, Chauzy C, Thiberville L, Martin J . Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains. Int J Cancer. 2002; 97(5):615-20. DOI: 10.1002/ijc.10120. View

16.

Zhang B, Chen J, Chen D, Wang G, Shen P . Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls. World J Gastroenterol. 2004; 10(11):1643-6. PMC: 4572770. DOI: 10.3748/wjg.v10.i11.1643. View

17.

Anderson N, Anderson N . The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics. 2002; 1(11):845-67. DOI: 10.1074/mcp.r200007-mcp200. View

18.

Huang L, Yoneda M, Kimata K . A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J Biol Chem. 1993; 268(35):26725-30. View

19.

Amonkar S, Bertenshaw G, Chen T, Bergstrom K, Zhao J, Seshaiah P . Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS One. 2009; 4(2):e4599. PMC: 2643010. DOI: 10.1371/journal.pone.0004599. View

20.

Ho J, Kong J, Choong L, Loh M, Toy W, Chong P . Novel breast cancer metastasis-associated proteins. J Proteome Res. 2008; 8(2):583-94. DOI: 10.1021/pr8007368. View